These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 17070147)

  • 21. Efficacy and safety of ETC-1002, a novel investigational low-density lipoprotein-cholesterol-lowering therapy for the treatment of patients with hypercholesterolemia and type 2 diabetes mellitus.
    Gutierrez MJ; Rosenberg NL; Macdougall DE; Hanselman JC; Margulies JR; Strange P; Milad MA; McBride SJ; Newton RS
    Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):676-83. PubMed ID: 24385236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Baseline achievement of lipid goals and usage of lipid medications in patients with diabetes mellitus (from the Veterans Affairs Diabetes Trial).
    Meyers CD; McCarren M; Wong ND; Abraira C; Duckworth WC; Kashyap ML;
    Am J Cardiol; 2006 Jul; 98(1):63-5. PubMed ID: 16784922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial.
    Lee JK; Grace KA; Taylor AJ
    JAMA; 2006 Dec; 296(21):2563-71. PubMed ID: 17101639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of time-of-day of hypertension treatment on ambulatory blood pressure and clinical characteristics of patients with type 2 diabetes.
    Moyá A; Crespo JJ; Ayala DE; Ríos MT; Pousa L; Callejas PA; Salgado JL; Mojón A; Fernández JR; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):116-31. PubMed ID: 23181613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-density lipoprotein size and subclasses are markers of clinically apparent and non-apparent atherosclerosis in type 2 diabetes.
    Berneis K; Jeanneret C; Muser J; Felix B; Miserez AR
    Metabolism; 2005 Feb; 54(2):227-34. PubMed ID: 15690318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Normal LDL-Cholesterol Levels Are Associated With Subclinical Atherosclerosis in the Absence of Risk Factors.
    Fernández-Friera L; Fuster V; López-Melgar B; Oliva B; García-Ruiz JM; Mendiguren J; Bueno H; Pocock S; Ibáñez B; Fernández-Ortiz A; Sanz J
    J Am Coll Cardiol; 2017 Dec; 70(24):2979-2991. PubMed ID: 29241485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A pilot randomized trial comparing an intensive versus a standard intervention in stable HIV-infected patients with moderate-high cardiovascular risk.
    Masiá M; Bernal E; Padilla S; García N; Escribano JC; Martínez E; Gutiérrez F
    J Antimicrob Chemother; 2009 Sep; 64(3):589-98. PubMed ID: 19625372
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors associated with therapeutic goal attainment in patients with concomitant hypertension and dyslipidemia.
    Chopra I; Kamal KM
    Hosp Pract (1995); 2014 Apr; 42(2):77-88. PubMed ID: 24769787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Statins and diabetes.
    Carmena R; Betteridge DJ
    Semin Vasc Med; 2004 Nov; 4(4):321-32. PubMed ID: 15861314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: a retrospective study using an electronic medical records dataset in the United States.
    Fox KM; Gandhi SK; Ohsfeldt RL; Blasetto JW; Bays HE
    Curr Med Res Opin; 2007 Sep; 23(9):2125-33. PubMed ID: 17655813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of hyperlipidemia in primary practise in Germany: sub-group analyses from the 4E-registry with particular emphasis on men and women with diabetes mellitus.
    Assmann G; Schulte H; Cullen P; Neiss A; Bestehorn K
    Exp Clin Endocrinol Diabetes; 2007 Feb; 115(2):85-91. PubMed ID: 17318766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cholesterol-lowering effect of concentrated pomegranate juice consumption in type II diabetic patients with hyperlipidemia.
    Esmaillzadeh A; Tahbaz F; Gaieni I; Alavi-Majd H; Azadbakht L
    Int J Vitam Nutr Res; 2006 May; 76(3):147-51. PubMed ID: 17048194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term (18-month) efficacy of atorvastatin therapy in type 2 diabetics at cardiovascular risk.
    Velussi M
    Nutr Metab Cardiovasc Dis; 2002 Feb; 12(1):29-35. PubMed ID: 12125227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimal medical management of peripheral arterial disease.
    Rice TW; Lumsden AB
    Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The relationship between hyperlipidemia and lower limb arterial disease in elderly diabetes patients].
    Chen XH; Lu ZL; Guo FJ; Tang ZY
    Zhonghua Nei Ke Za Zhi; 2008 Jul; 47(7):556-9. PubMed ID: 19035165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of LDL cholesterol and inflammation with cardiovascular events and mortality in hemodialysis patients with type 2 diabetes mellitus.
    Krane V; Winkler K; Drechsler C; Lilienthal J; März W; Wanner C;
    Am J Kidney Dis; 2009 Nov; 54(5):902-11. PubMed ID: 19781835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Indications for lowering LDL cholesterol in rheumatoid arthritis: an unrecognized problem.
    Soubrier M; Zerkak D; Dougados M
    J Rheumatol; 2006 Sep; 33(9):1766-9. PubMed ID: 16845709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diabetes and cardiovascular disease.
    Howard BV; Magee MF
    Curr Atheroscler Rep; 2000 Nov; 2(6):476-81. PubMed ID: 11122781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of improvement in the treatment of hyperlipidemia among patients with type 2 diabetes.
    Mehler PS; Esler A; Estacio RO; MacKenzie TD; Hiatt WR; Schrier RW
    Am J Med; 2003 Apr; 114(5):377-82. PubMed ID: 12714127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The therapeutic impacts of tocotrienols in type 2 diabetic patients with hyperlipidemia.
    Baliarsingh S; Beg ZH; Ahmad J
    Atherosclerosis; 2005 Oct; 182(2):367-74. PubMed ID: 16159610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.